全球肌腱板損傷治療市場：未來按方式(關節鏡檢查,肩關節置換術,肌腱修復),物理治療(支架,冷卻按壓),藥物治療(抗炎劑,注射劑),骨科預測至2026

全球肩袖損傷治療市場預計將從 2021 年的 8.99 億美元增長到 2026 年的 12.44 億美元。

此外，預測期間的複合年增長率預計為 4.7%。市場的主要驅動力是運動相關肩關節疾病的增加、關節鏡手術設備的技術進步、患有骨關節炎的老年人口的增加以及旨在推出先進關節鏡治療設備的公司，這包括對部分的興趣增加

按類型，手術或根治性治療是最大的部分。按地區劃分，預計亞太地區在預測期內將以最高的複合年增長率增長。

本報告分析了全球肌腱板損傷治療市場，分析了市場的基本結構和最新情況、主要市場促進/制約因素、市場趨勢前景、按類型(按方式)和按地區。我們正在調查詳細的趨勢、市場競爭狀況、主要公司的概況等。

目錄

第一章介紹

第二章調查方法

第 3 章執行摘要

第 4 章市場概述

• 簡介
• 市場動態
  • 行業增長機會
  • 燃燒問題和挑戰
  • 冠狀病毒感染 (COVID-19)：獨特趨勢
• 監管狀態
• 兌換場景
• 價格趨勢分析
• 臨床研究管道
• 專利分析

第 5 章肩袖損傷治療市場：按類型

• 簡介
• 手術/根治性治療
  • 常規/開放手術
  • 關節鏡檢查(肌腱修復)
• 物理治療、姑息治療
  • 矯形支具(矯形器)
  • 冷壓療法
• 藥品、預防性治療
  • 消炎鎮痛
  • 注入
• 骨科

第 6 章肩袖損傷治療市場：按地區劃分

• 簡介
• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東/非洲

第7章競爭態勢

• 概覽
  • 大公司的戰略
• 在每個治療區域運營的主要公司列表
  • 產品組合/開發管道
  • 主要戰略/成功戰略
• 衝突場景
  • 肩袖損傷治療市場：產品發布和監管批准
  • 肩袖損傷治療市場：資本市場
  • 肩袖損傷治療市場：其他發展
  • 競爭領導力圖譜
• 肩袖損傷治療市場主要公司的足跡分析
  • 肩袖損傷治療市場的頂級公司：治療產品和區域足跡分析

第 8 章公司簡介

• 主要公司
  • STRYKER CORPORATION
  • JOHNSON & JOHNSON
  • SMITH & NEPHEW
  • ARTHREX
  • ZIMMER BIOMET
  • INTEGRA LIFESCIENCES
  • LIMACORPORATE S.P.A
  • DJO GLOBAL, INC.
  • EVOLUTIS
  • GROUP FH ORTHO
  • CONMED CORPORATION
  • 3S ORTHO
  • ANIKA THERAPEUTICS, INC. (PARCUS MEDICAL)
  • GPC MEDICAL LTD.
  • BREG, INC.

第9章 附錄

The global rotator cuff injury treatment market is projected to reach USD 1,244 million by 2026 from USD 989 million in 2021, at a CAGR of 4.7% during the forecast period". The key factors fueling the growth of this market include an increase in sports related shoulder injuries, technological advancements in arthroscopic surgical devices, increase in the aging population with osteoarthritis, strong focus of players towards launch of highly advanced arthroscopic treatment devices. On the other hand, a dearth of skilled professionals, a high surgical treatment failure rate, and its high cost are major challenges faced by market players providing rotator cuff injury treatment products.

The COVID-19 pandemic is an unprecedented crisis that has significantly strained healthcare providers, healthcare infrastructure, and healthcare systems worldwide. The COVID-19 pandemic had a remarkable change in several aspects of medical practice. Elective surgeries, including orthopedic surgery, were canceled worldwide, allowing hospitals to accommodate more COVID-19 patients and completely focus on reducing the possible risk of infection among healthcare workers. According to The CovidSurg Collaborative, a 120-country research initiative formed to analyze the impact of the COVID-19 pandemic on surgeries, around 28.4 million elective surgeries worldwide will be canceled or postponed in 2020, based on 12 weeks of peak disruption to hospital services due to COVID-19. The rotator cuff injury treatment market was also impacted due to restrictions on the organized temporary closure of surgical centers, hospital access restriction for non-essential care, limited access to clinics, implementation of social distancing measures, nationwide lockdowns, and the slowdown of in-patient flow and referrals.

"The surgical or curative treatment to capture the largest share in rotator cuff injury treatment market, by type during the forecast period."

The surgical treatment segment is expected to hold the largest share of rotator cuff injury treatment market, during the forecast period. This is attributable to the high adoption due to the increasing prevalence of rotator cuff injuries majorly among sportspersons, rising awareness activities by major market players across key countries, and the availability of medical reimbursements for surgical treatment of rotator cuff rupture. Additionally, the increase in the preference of shoulder arthroscopy for the treatment rotator cuff tear among surgeons and the growing awareness about the benefits associated with arothrocopic repair such as lower risk of complications, quick recovery, low rate of post surgical infections are likely to play a significant role in propelling the growth of the segment.

"The Asia Pacific market to grow at the highest CAGR during the forecast period."

The rotator cuff injury treatment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. significant increase in its geriatric and patient population for orthopedic diseases, growing adoption of orthopedic bracing products in developing nations of Asia Pacific, growing presence of rotator cuff injury treatment devices and drugs manufacturers in the country, increase in the initiatives by the government to promote sports, and growing adoption of new surgical devices for rotator cuff tears launched by local manufacturers are likely to support the growth of the market in the region.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
• By Designation: C-level: 26%, D-level: 30%, and Others: 44%
• By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%

Arthrex (US), Stryker Corporation (US), Smith & Nephew (UK), Johnson & Johnson (DePuy Synthes) (US), Zimmer Biomet (US), CONMED Corporation (US), Integra LifeSciences Corporation (US), LimaCorporate (Italy), FH ORTHOPEDICS S.A.S. (France), Evolutis India Pvt Ltd. (India), DJO Global (US), 3S Ortho (France), Breg, Inc. (US), GPC Medical Ltd. (India), and Parcus Medical (US).

Research Coverage

This report studies the global rotator cuff injury treatment market based on the treatment type, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the global in rotator cuff injury treatment market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 OBJECTIVES OF THE STUDY
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED FOR THE STUDY
• 1.4 CURRENCY USED FOR THE STUDY
• 1.5 MAJOR MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA SOURCES
    • 2.1.1.1 Secondary Data Sources
  • 2.1.2 PRIMARY DATA SOURCES
  • FIGURE 2 BREAKDOWN OF PRIMARIES: ROTATOR CUFF RUPTURE TREATMENT MARKET
• 2.2 MARKET ESTIMATION METHODOLOGY
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
  • 2.2.2 TREATMENT USAGE-BASED MARKET ESTIMATION
  • FIGURE 4 MARKET SIZE ESTIMATION BASED ON TREATMENT UTILIZATION METHODOLOGY
  • FIGURE 5 MARKET SIZE ESTIMATION BASED ON REVENUE MAPPING METHODOLOGY
  • 2.2.3 PRIMARY RESEARCH VALIDATION
• 2.3 DATA TRIANGULATION
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

• 3.1 ROTATOR CUFF RUPTURE TREATMENT MARKET
  • FIGURE 7 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
  • FIGURE 8 MARKET OPPORTUNITY IN ROTATOR CUFF RUPTURE TREATMENT MARKET DURING 2020-2026 (USD MN)

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 INDUSTRY GROWTH OPPORTUNITIES
    • 4.2.1.1 Rising number of sports-related shoulder injuries
  • FIGURE 9 INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES IN THE US PER 1000 INHABITANATS (2020)
    • 4.2.1.2 Technological advancements in rotator cuff rupture devices
    • 4.2.1.3 Growing public-private funding grants and educational awareness initiatives
    • 4.2.1.4 Increasing risk of osteoarthritis in the geriatric population
  • TABLE 1 NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION (2019 VS. 2050)
    • 4.2.1.5 Growing developments in orthobiologics
  • 4.2.2 BURNING ISSUES AND CHALLENGES
    • 4.2.2.1 High costs associated with arthroscopic surgical procedures
    • 4.2.2.2 High failure rates of rotator cuff surgical treatment
    • 4.2.2.3 Shortage of trained orthopedic professionals
  • 4.2.3 COVID-19 SPECIFIC TRENDS
• 4.3 REGULATORY LANDSCAPE
  • 4.3.1 NORTH AMERICA
    • 4.3.1.1 US
  • TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 4.3.1.2 Canada
  • TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • FIGURE 10 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (CMDR)
  • 4.3.2 EUROPE
  • FIGURE 11 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
  • 4.3.3 ASIA PACIFIC
    • 4.3.3.1 India
    • 4.3.3.2 Japan
  • TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
    • 4.3.3.3 China
  • TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
    • 4.3.3.4 India
• 4.4 REIMBURSEMENT SCENARIO
  • TABLE 7 REIMBURSEMENT CODES FOR PHYSICIAN SERVICES (AS OF 2020)
  • TABLE 8 REIMBURSEMENT CODES FOR OUTPATIENT SERVICES (AS OF 2020)
• 4.5 PRICING TREND ANALYSIS
  • TABLE 9 AVERAGE PRICE OF ROTATOR CUFF TREATMENT INSTRUMENTS, BY REGION COUNTRY, 2020 (USD)
• 4.6 CLINICAL RESEARCH PIPELINE
  • 4.6.1 ROTATOR CUFF REPAIR TREATMENT
  • TABLE 10 ROTATOR CUFF REPAIR: INDICATIVE LIST OF ONGOING CLINICAL TRIALS (AS OF 2021)
• 4.7 PATENT ANALYSIS
  • FIGURE 12 TOP 10 PATENT APPLICANTS FOR ROTATOR CUFF REPAIR (JANUARY 2011 TO OCTOBER 2021)
  • FIGURE 13 NUMBER OF GRANTED PATENTS AND PATENT APPLICATIONS (JANUARY 2011 TO OCTOBER 2021)
  • FIGURE 14 PATENT DOCUMENTS FOR ROTATOR CUFF REPAIR, BY LEGAL STATUS (JANUARY 2011 TO OCTOBER 2021)
  • FIGURE 15 REGIONAL ANALYSIS OF PATENTS GRANTED FOR ROTATOR CUFF REPAIR, 2020

5 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE

• 5.1 INTRODUCTION
  • TABLE 11 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
• 5.2 SURGICAL OR CURATIVE TREATMENT
  • 5.2.1 TRADITIONAL/OPEN SURGERIES
    • 5.2.1.1 Shoulder replacement surgeries
    • 5.2.1.2 Open tendon repair/transfer
  • 5.2.2 ARTHROSCOPY (TENDON REPAIR)
  • TABLE 12 ARTHOSCOPY TREATMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
• 5.3 PHYSIOTHERAPY OR PALLIATIVE TREATMENT
  • TABLE 13 PHYSIOTHERAPY TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 5.3.1 ORTHOPEDIC BRACES
  • TABLE 14 ORTHOPEDIC BRACES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 5.3.2 COLD COMPRESSION THERAPY
  • TABLE 15 COLD COMPRESSION THERAPY MARKET, BY REGION, 2019-2026 (USD MILLION)
• 5.4 PHARMACEUTICAL DRUGS OR PREVENTIVE TREATMENT
  • TABLE 16 PHARMACEUTICAL DRUGS MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 5.4.1 ANTI-INFLAMMATORY DRUGS AND PAIN KILLERS
  • TABLE 17 ANTI-INFLAMMATORY DRUGS AND PAIN KILLERS MARKET, 2019-2026 (USD MILLION)
  • 5.4.2 INJECTIONS
  • TABLE 18 INJECTIONS MARKET, BY TYPE, 2019-2026 (USD MILLION)
• 5.5 ORTHOBIOLOGICS
  • TABLE 19 ORTHOBIOLOGICS MARKET, BY TYPE, 2019-2026 (USD MILLION)

6 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY REGION

• 6.1 INTRODUCTION
  • TABLE 20 ROTATOR CUFF RUPTURE TREATMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
• 6.2 NORTH AMERICA
  • TABLE 21 NORTH AMERICA ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
• 6.3 EUROPE
  • TABLE 22 EUROPE ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
• 6.4 ASIA PACIFIC
  • TABLE 23 ASIA PACIFIC ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
• 6.5 LATIN AMERICA
  • TABLE 24 LATIN AMERICA ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
• 6.6 MIDDLE EAST & AFRICA
  • TABLE 25 MIDDLE EAST & AFRICA ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)

7 COMPETITIVE LANDSCAPE

• 7.1 OVERVIEW
  • 7.1.1 KEY PLAYER STRATEGIES
• 7.2 LIST OF KEY PLAYERS OPERATING IN EACH TREATMENT SPACE
  • 7.2.1 PRODUCT PORTFOLIO/DEVELOPMENT PIPELINE
  • 7.2.2 KEY STRATEGIES/RIGHT TO WIN
• 7.3 COMPETITIVE SCENARIO
  • 7.3.1 ROTATOR CUFF RUPTURE TREATMENT MARKET: PRODUCT LAUNCHES & REGULATORY APPROVALS
  • TABLE 26 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS, JANUARY 2018-OCTOBER 2021
  • 7.3.2 ROTATOR CUFF RUPTURE TREATMENT MARKET: DEALS
  • TABLE 27 KEY DEALS, JANUARY 2018-OCTOBER 2021
  • 7.3.3 ROTATOR CUFF RUPTURE TREATMENT MARKET: OTHER DEVELOPMENTS
  • TABLE 28 OTHER KEY DEVELOPMENTS, JANUARY 2018-OCTOBER 2021
  • 7.3.4 COMPETITIVE LEADERSHIP MAPPING
    • 7.3.4.1 Stars
    • 7.3.4.2 Pervasive players
    • 7.3.4.3 Emerging leaders
    • 7.3.4.4 Participants
  • FIGURE 16 ROTATOR CUFF RUPTURE TREATMENT MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
• 7.4 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ROTATOR CUFF RUPTURE TREATMENT MARKET
  • 7.4.1 TREATMENT PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ROTATOR CUFF RUPTURE TREATMENT MARKET
  • TABLE 29 TREATMENT PRODUCT FOOTPRINT OF COMPANIES
  • TABLE 30 REGIONAL FOOTPRINT OF COMPANIES

8 COMPANY PROFILES

• 8.1 KEY PLAYERS
• (Business overview, Products offered, Recent developments, and MnM view)**
• 8.1.1 STRYKER CORPORATION
• TABLE 31 STRYKER CORPORATION: BUSINESS OVERVIEW
• FIGURE 17 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
• 8.1.2 JOHNSON & JOHNSON
• TABLE 32 JOHNSON & JOHNSON: BUSINESS OVERVIEW
• FIGURE 18 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
• 8.1.3 SMITH & NEPHEW
• TABLE 33 SMITH & NEPHEW: BUSINESS OVERVIEW
• FIGURE 19 SMITH & NEPHEW: COMPANY SNAPSHOT (2020)
• 8.1.4 ARTHREX
• TABLE 34 ARTHREX: BUSINESS OVERVIEW
• 8.1.5 ZIMMER BIOMET
• TABLE 35 ZIMMER BIOMET: BUSINESS OVERVIEW
• FIGURE 20 ZIMMER BIOMET: COMPANY SNAPSHOT (2020)
• 8.1.6 INTEGRA LIFESCIENCES
• TABLE 36 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW
• FIGURE 21 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020)
• 8.1.7 LIMACORPORATE S.P.A
• TABLE 37 LIMACORPORATE: BUSINESS OVERVIEW
• FIGURE 22 LIMACORPORATE: COMPANY SNAPSHOT (2020)
• 8.1.8 DJO GLOBAL, INC.
• TABLE 38 DJO GLOBAL, INC.: BUSINESS OVERVIEW
• FIGURE 23 DJO GLOBAL, INC.: COMPANY SNAPSHOT (2020)
• 8.1.9 EVOLUTIS
• TABLE 39 EVOLUTIS: BUSINESS OVERVIEW
• 8.1.10 GROUP FH ORTHO
• TABLE 40 GROUP FH ORTHO: BUSINESS OVERVIEW
• 8.1.11 CONMED CORPORATION
• TABLE 41 CONMED CORPORATION: BUSINESS OVERVIEW
• FIGURE 24 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
• 8.1.12 3S ORTHO
• TABLE 42 3S ORTHO: BUSINESS OVERVIEW
• 8.1.13 ANIKA THERAPEUTICS, INC. (PARCUS MEDICAL)
• TABLE 43 ANIKA THERAPEUTICS: BUSINESS OVERVIEW
• FIGURE 25 ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2020)
• 8.1.14 GPC MEDICAL LTD.
• TABLE 44 GPC MEDICAL LTD.: BUSINESS OVERVIEW
• 8.1.15 BREG, INC.
• TABLE 45 BREG, INC.: BUSINESS OVERVIEW
• *Details on Business overview, Products offered, Recent developments, and MnM view not be captured in case of unlisted companies.

9 APPENDIX

• 9.1 DISCUSSION GUIDE
• 9.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 9.3 RELATED REPORTS
• 9.4 AVAILABLE CUSTOMIZATIONS